American Bio Medica Corporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 0.614 million compared to USD 0.883 million a year ago. Net income was USD 0.663 million compared to net loss of USD 0.216 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the nine months, sales was USD 1.71 million compared to USD 3.37 million a year ago. Net loss was USD 0.138 million compared to USD 0.563 million a year ago.